ADDvise Group publishes its interim report October 1 – December 31, 2024 on Thursday, February 20, 2025 at 7.45 am (CET). Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and Interim CFO, Johan Irwe, will present the report. Webcast If you…
Read moreMedia, investors and analysts are invited to attend a presentation of the interim report for the period July 1 – September 30, 2024. The presentation will take place on October 24, 2024, at 14:00 (CEST) / 08:00 AM (EST). CEO, Staffan Torstensson, and Interim CFO, Johan Irwe, will present the report in a webcast and…
Read moreThe chairman of the board and incoming CEO Staffan Torstensson has today, privately and through companies, divested 610,000 shares of series A to Kenneth Lindqvist, one of the major shareholders of ADDvise, privately and through companies. The total purchase price for the shares amounted to SEK 9,150,000. In conjunction with the divestment of the shares…
Read moreADDvise Group’s interim report for the period January 1 – March 31, 2024 will be published on April 18, 2024 at 07:45 (CEST). Investors, analysts, and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will…
Read moreADDvise Group’s year-end report for the period January 1 – December 31, 2023 will be published on February 22, 2024 at 07:45 (CET). Investors, analysts and other stakeholders are invited to a webcast and conference call at 14:00 (CET) / 08:00 AM (ET) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will…
Read moreADDvise Group’s interim report for the period July 1 – September 30, 2023 will be published on October 26, 2023 at 07:45 (CEST). Investors, analysts and other stakeholders are invited to a webcast and conference call at 14:00 (CEST) / 08:00 AM (EST) the same day where CEO Rikard Akhtarzand and CFO Oliver Humlen will…
Read moreStockholm, July 6, 2023 Invitation to presentation of interim report April 1 – June 30, 2023 Media, investors and analysts are on the same day invited to attend a presentation of the interim report April 1 – June 30, 2023 at July 20 13:00 (CEST), 07:00 AM (EST). The CEO, Rikard Akhtarzand, will present the…
Read moreMedia, investors and analysts are on the same day invited to attend a presentation of the interim report January 1 – March 31, 2023 at April 20 13:00 (CEST), 07:00 AM (EST). The CEO, Rikard Akhtarzand, will present the report in a webcast and telephone conference. Webcast If you wish to participate via webcast, please…
Read moreThe board of directors of ADDvise Group AB has today been informed that one of its major shareholders, Per Åhlgren through GoMobile nu Aktiebolag, has issued call options in ADDvise Group AB to board members, senior executives and certain other employees in ADDvise Group. In total, 3,696,666 call options have been issued to eleven persons.…
Read moreIn accordance with the resolution at the 2019 annual general meeting of ADDvise Group AB the nomination committee for the annual general meeting 2020 shall be composed of representatives of the three largest shareholders by votes listed in the shareholders’ register maintained by Euroclear Sweden as of 31 August 2019 and the chairman of the…
Read moreYear-end report 2019 (Jan-Dec): 2020-02-20 Annual shareholder meeting: 2020-04-24 Three-month report (Jan-March): 2020-04-24 Six-month report (Jan-Jun): 2020-07-24 Nine-month report (Jan-Sep): 2020-10-23 Year-end report 2020 (Jan-Dec): 2021-02-25 For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se About ADDvise Group ADDvise Group AB (publ) is a leading supplier of equipment to healthcare…
Read moreToday ADDvise Group announces that Analyst Group published a research report of ADDvise Group on Analyst Group’s website and can be found at https://analystgroup.se/analysis/addvise-group/ For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se About ADDvise Group ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The…
Read moreADDvise Group has the 26th of October 2018 published the reporting dates for 2019. New date for the annual shareholder meeting 2019 is April 25th 2019. For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhatrzand@addvisegroup.se About ADDvise Group ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research…
Read more• Year-end report 2018: 2019-02-21 • Annual shareholder meeting: 2019-04-23 • Three-month report (Jan-March): 2019-04-25 • Six-month report (Jan-Jun): 2019-07-23 • Nine-month report (Jan-Sep): 2019-10-22 • Year-end report 2019 (Jan-Dec): 2020-02-20 For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se About ADDvise Group ADDvise Group AB (publ) is a leading supplier of…
Read moreThe tender covers anesthesia and intensive care supplies. The agreement runs for 2 years with an option of another 2 years. Value on an annual basis is approximately 0.9 MSEK. Delivery will start on June 1st, 2017. – Femklövern is one of our major customers. We are pleased and grateful for the continued confidence, says…
Read more· The subscription price amounts to 1.82 SEK per share based on a VWAP. · The issue provides ADDvise with approximately 5.1 MSEK. · The reason for deviation from the shareholders preferential rights and the motives for the share issue is to repay debt and thereby strengthen the capital structure of the Company. · The…
Read moreReasons for the acquisition Hettich contributes to a significant increase in ADDvise’s net sales and operating profit. The Acquisition is strategically important for ADDvise and will increase the range of products and strengthen the competence within the group. The Acquisition will generate both industrial and financial synergies. –”An acquisition of Hettich enables a higher growth…
Read more– It is gratifying to see that our investment in instruments and equipment for research facilities and healthcare continues to yield results, says Rikard Akhtarzand CEO of ADDvise Group in a comment to the allocation decision. The agreement has a standstill period until October 24. Not until then ADDvise Tillquist AB has the right…
Read more– Our investment in instruments and equipment for research facilities and healthcare gives results. The growth in this segment is very good, says Rikard Akhtarzand CEO of ADDvise Group in a comment to the order. The agreement has a standstill period until August 29. Not until then LabRum AB has the right to sign the…
Read more· The order shows the strength of the acquisition of LabRum. Through LabRum ADDvise gets a much better presence on the Norwegian market of laboratory furnishings and safety ventilation, says Rikard Akhtarzand, CEO of ADDvise Group in a comment on today’s order. The order amounts to approximately 4.3 MNOK. Delivery will take place during the…
Read moreThe order amounts to 1.2 MSEK. Delivery will take place during the third quarter of 2016. For further information, please contact: Rikard Akhtarzand, CEO, +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se www.addvisegroup.com About ADDvise Group AB ADDvise Group AB (publ) is an expansive group which through its subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige…
Read more– We are very satisfied to sign this agreement with a partner that has proven competence and long experience from this market, says Erland Pontusson, Senior Vice President. This is also in line with Surgical Tables international expansion going forward. For further information, please contact: Rikard Akhtarzand, CEO, +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se www.addvisegroup.com…
Read moreThe COO will be responsible for all operating subsidiaries and thus the overall operations of the Group. The tasks to provide subsidiary assistance and support in their daily work will primarily be on the newly created position of COO. COO will also be responsible for identifying and exploiting possible synergies between acquired units. The goal…
Read moreNorth America and especially the Middle East are markets which in recent years have shown a strong purchasing power for both mobile examination table and products for urology and gynecology. We are very pleased to have signed a contract with just AlphaPro, who is a distributor with good contacts in the current market and with…
Read moreBengt Miller, acting CFO for ADDvise Group, will remain in his role until Anna starts. For further information, please contact: Rikard Akhtarzand, CEO, +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se www.addvisegroup.com About ADDvise Group AB ADDvise Group AB (publ) is an expansive group which through its subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise…
Read more– This is the second order from AstraZeneca in Wuxi in a short time. It is exciting that we have continued confidence from AstraZeneca and that ADDvise products continue to be competitive in the Chinese market, says Rikard Akhtarzand CEO of ADDvise, in a comment on today's order. For further information, please contact: Rikard…
Read moreAbout the loan The loan amounts to 18 million SEK in a credit line of 20 million SEK. The loan will bear market interest. Repayment shall be made by December 28th 2018 and the loan is amortized quarterly from June 30th 2016. The loan will be used to complete the financing of the acquisition of…
Read moreMotives for the acquisition The acquisition of LabRum is another step in the growth strategy adopted by the Board of ADDvise in early 2010. LabRum contributes to a significant increase in ADDvise turnover and operating profit. The acquisition is strategically important for the business area Lab and will expand the range of products, strengthen the…
Read moreThe Board of ADDvise resolved on February 1st 2016 to issue 2 173 000 shares of series B at a price of 2.10 SEK with deviation from the shareholders' preferential rights. The issue offsets the holder's nominal bond claim against ADDvise of approximately 5.0 million SEK, including accrued interest as of the date of settlement, which…
Read moreThe reason for deviation from the shareholders preferential rights and the motives for the share issue is to finance the acquisition of LabRum AB and broaden the shareholder base with qualified investors. The issue increases the number of shares of series B in the Company by 3,791,469 shares. The company's total number of outstanding shares…
Read moreThe purpose of the issue was to gain a greater spread of ownership of the company and to raise capital to finance future acquisition and to further strengthen its financial position. A greater spread of ownership creates conditions for a better share liquidity before the planned listing on the Nasdaq Stockholm. The contract note will…
Read moreInnovation Skåne is a company wholly owned by Region Skåne, they make use of and develop ideas that are emerging in the employees’ everyday work in the region to increase the quality and efficiency in the healthcare. IM-Medico is a well-known player in the medical technology market and they already have a broad customer base…
Read moreBengt Miller holds an MBA degree and has a background as a Certified Accountant at Ernst & Young. Bengt Miller also has extensive experience as CFO of several medium-sized companies. During parts of 2013 Bengt was engaged as interim-CFO of ADDvise Group. For further information, please contact: Rikard Akhtarzand, CEO, +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se (rikard.akhtarzand@addvisegroup.se)…
Read moreFor further information, please contact: Rikard Akhtarzand, CEO, +46 765-25 90 71 rikard.akhtarzand@addvisegroup.se www.addvisegroup.com About ADDvise Group AB ADDvise Group AB (publ) is an expansive group which through its subsidiaries IM-Medico Svenska AB, KEBO Inredningar Sverige AB, ADDvise Tillquist AB, Sonesta Medical AB, Sonesta Medical Inc and Surgical Tables Inc offers comprehensive solutions…
Read moreThe order consists of specially developed safety cabinets to the clean room that ADDvise delivered to NKS during 2015. – Today's order determine ADDvise wide product range and confirms ADDvise as a comprehensive supplier. We are proud to once again deliver products to Skanska Healthcare, says Rikard Akhtarzand CEO of ADDvise, in a comment on…
Read moreMeg Tivéus has many years of experience in senior management and Board positions in both the private and public sectors in Sweden and internationally. For the past nine years Meg has been working full time as a member of the board for various companies. She is currently a Board member of Swedish Match AB, Endomines…
Read more